Home | Links | FAQs | Contact | Feedback 
US, Canadian and Australia FAQs

Frequently Asked Questions for the IMS3 Trial are compiled here. The questions with answers address some of the most common questions and issues that arise during trial implementation.

Question 1:

Is the trial still looking for additional centers?
We are still evaluating /screening centers. If you are interested in becoming an IMS III site please contact Ms. Rose Beckman by email to discuss involvement.

Question 2:

 What is the NIHSS Certification policy for IMS III?
Annual re-certification is required for clinical examiners in the trial. Re-certification is also required for the Modified-Rankin Scale.

Quick tip

Grant Number:
U01 N052220

FDA Number: 5785

Need fast help?